0001542968-15-000001.txt : 20150619 0001542968-15-000001.hdr.sgml : 20150619 20150619135049 ACCESSION NUMBER: 0001542968-15-000001 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150617 FILED AS OF DATE: 20150619 DATE AS OF CHANGE: 20150619 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARGOS THERAPEUTICS INC CENTRAL INDEX KEY: 0001105533 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 562110007 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4233 TECHNOLOGY DR CITY: DURHAM STATE: NC ZIP: 27704 BUSINESS PHONE: 9192876300 MAIL ADDRESS: STREET 1: 4233 TECHNOLOGY DR CITY: DURHAM STATE: NC ZIP: 27704 FORMER COMPANY: FORMER CONFORMED NAME: MERIX BIOSCIENCE INC DATE OF NAME CHANGE: 20000207 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Plessinger Douglas C. CENTRAL INDEX KEY: 0001542968 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35443 FILM NUMBER: 15941964 MAIL ADDRESS: STREET 1: 4233 TECHNOLOGY DRIVE CITY: DURHAM STATE: NC ZIP: 27704 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2015-06-17 0 0001105533 ARGOS THERAPEUTICS INC ARGS 0001542968 Plessinger Douglas C. 4233 TECHNOLOGY DRIVE DURHAM NC 27704 0 1 0 0 See Remarks Stock Option (right to buy) 7.8 2015-06-17 4 A 0 30000 0 A 2025-06-16 Common Stock 30000 30000 D This option was granted on June 17, 2015 and vests as to 25% of the shares underlying this option on June 17, 2016, with the remaining 75% of the shares underlying this option vesting in equal amounts monthly over the next three years beginning June 17, 2016. Vice President of Clinical and Medical Affairs Lori R. Harrelson, as attorney-in-fact 2015-06-19